REGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational UpdatesPRNewsWire • 03/13/25
REGENXBIO Announces Presentations at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific ConferencePRNewsWire • 03/10/25
Will Regenxbio (RGNX) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 03/06/25
REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS DiseasesPRNewsWire • 03/04/25
REGENXBIO to Host Conference Call on March 13 to Discuss Fourth Quarter and Full Year 2024 Financial Results and Recent Operational HighlightsPRNewsWire • 02/26/25
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs WarnsBenzinga • 02/11/25
Wall Street Analysts Think Regenxbio (RGNX) Could Surge 333.01%: Read This Before Placing a BetZacks Investment Research • 02/10/25
REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025PRNewsWire • 01/30/25
Wall Street Analysts See a 357.36% Upside in Regenxbio (RGNX): Can the Stock Really Move This High?Zacks Investment Research • 01/24/25
REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS DiseasesPRNewsWire • 01/14/25
Apollo Global Management and Workday Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600PRNewsWire • 12/06/24
REGENXBIO INITIATES PIVOTAL PHASE OF AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY AND REPORTS POSITIVE FUNCTIONAL DATAPRNewsWire • 11/18/24
REGENXBIO to Host Webcast Discussing Pivotal Program and First Functional Data from the AFFINITY DUCHENNE® Trial of RGX-202PRNewsWire • 11/14/24
REGENXBIO Reports Third Quarter 2024 Financial Results and Recent Operational UpdatesPRNewsWire • 11/06/24
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2024 Financial Results and Recent Operational HighlightsPRNewsWire • 10/30/24
REGENXBIO Presents Positive Data from the Phase II Study of Subretinal ABBV-RGX-314 in Patients with Bilateral Wet AMD at AAO 2024PRNewsWire • 10/21/24
REGENXBIO Announces Presentations at the American Academy of Ophthalmology 2024 Annual MeetingPRNewsWire • 10/18/24